Europlasma S.A. (EPA:ALEUP)
France flag France · Delayed Price · Currency is EUR
0.0002
0.00 (0.00%)
Nov 10, 2026, 3:37 PM CET

Europlasma Statistics

Total Valuation

Europlasma has a market cap or net worth of EUR 539,422. The enterprise value is 21.70 million.

Market Cap539,422
Enterprise Value 21.70M

Important Dates

The next estimated earnings date is Friday, November 13, 2026.

Earnings Date Nov 13, 2026
Ex-Dividend Date n/a

Share Statistics

Europlasma has 2.70 billion shares outstanding. The number of shares has increased by 108.51% in one year.

Current Share Class 2.70B
Shares Outstanding 2.70B
Shares Change (YoY) +108.51%
Shares Change (QoQ) +677,524.43%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.01
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.42
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.42

Current Ratio 0.42
Quick Ratio 0.18
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -34.00%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 265.02%
Weighted Average Cost of Capital (WACC) -10.69%
Revenue Per Employee 73,314
Profits Per Employee -50,707
Employee Count713
Asset Turnover 0.70
Inventory Turnover 1.75

Taxes

Income Tax -1.69M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -99.96% in the last 52 weeks. The beta is -99.28, so Europlasma's price volatility has been lower than the market average.

Beta (5Y) -99.28
52-Week Price Change -99.96%
50-Day Moving Average 0.00
200-Day Moving Average 0.01
Relative Strength Index (RSI) 37.21
Average Volume (20 Days) 52,008,115

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Europlasma had revenue of EUR 52.27 million and -36.15 million in losses. Loss per share was -0.05.

Revenue52.27M
Gross Profit 21.13M
Operating Income -40.54M
Pretax Income -40.63M
Net Income -36.15M
EBITDA -32.54M
EBIT -40.54M
Loss Per Share -0.05
Full Income Statement

Balance Sheet

The company has 1.02 million in cash and 26.80 million in debt, with a net cash position of -25.78 million or -0.01 per share.

Cash & Cash Equivalents 1.02M
Total Debt 26.80M
Net Cash -25.78M
Net Cash Per Share -0.01
Equity (Book Value) -42.77M
Book Value Per Share -0.15
Working Capital -45.81M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.43 million and capital expenditures -3.91 million, giving a free cash flow of -16.34 million.

Operating Cash Flow -12.43M
Capital Expenditures -3.91M
Depreciation & Amortization 8.00M
Net Borrowing 12.63M
Free Cash Flow -16.34M
FCF Per Share -0.01
Full Cash Flow Statement

Margins

Gross margin is 40.42%, with operating and profit margins of -77.56% and -69.16%.

Gross Margin 40.42%
Operating Margin -77.56%
Pretax Margin -77.73%
Profit Margin -69.16%
EBITDA Margin -62.25%
EBIT Margin -77.56%
FCF Margin n/a

Dividends & Yields

Europlasma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -108.51%
Shareholder Yield -108.51%
Earnings Yield -27,178.50%
FCF Yield -3,029.91%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on October 7, 2025. It was a reverse split with a ratio of 0.0004.

Last Split Date Oct 7, 2025
Split Type Reverse
Split Ratio 0.0004

Scores

Altman Z-Score n/a
Piotroski F-Score 1